• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Return of the Rx to OTC Switch – Market Analysis and Product Management Strategies, The

$500.00 – $3,990.00

Clear
SKU: KLI1692599 Categories: Manufacturing & Packaging, Over-the-Counter (OTC) Drugs, Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 52
  • Description
  • Table of Contents
  • Latest reports

Description

Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life.

Kalorama Information’s The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies contians a complete overview of the US market for prescription drugs likely to switch in the following drug categories:

  • Allergy and Cold
  • Antilipidemic Agents
  • Fungal Infections
  • Gastrointestinal Drugs
  • Hair Loss Treatments
  • Migraine Therapy
  • Nonsteroidal Anti-inflammatories
  • Oral Contraceptives
  • Osteoporosis and Hormone Replacement Therapies
  • Overactive Bladder
  • Sexual Dysfunction
  • Sleep Agents
  • Smoking Cessation
  • Viral Infections
  • Others

Kalorama Information believes this trend of utilizing Rx to OTC will continue. There are currently 14 prescription drugs, with worldwide prescription sales exceeding $20 billion in 2006, with the potential to reach the OTC market by the year 2013.

What are the most viable products that are candidates for Rx to OTC switches? Who are the players in the industry best suited to execute this strategy? What is the market potential for Rx to OTC in key categories? And what are the advantages and pitfalls of using this tactic in the current market? These questions and more are answered in this Kalorama Information report, the result of Moutaintop Medical’s exhaustive analysis and interviews with experts in the industry.

License Note: Kalorama Information’s listed default price on its information products reflects a single user license only. Purchasing a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Scope of the Report
  • Methodology
  • Issues and Trends

CHAPTER TWO: RX-TO-OTC PRODUCT AND MARKET ANALYSIS

  • Introduction
  • Allergy and Cold
    • Market Analysis
  • Antilipidemic Agents
    • Market Analysis
  • Fungal Infections
    • Market Analysis
  • Gastrointestinal
    • Market Analysis
  • Hair Loss
    • Market Analysis
  • Migraine Therapy
    • Market Analysis
  • NSAIDs
    • Market Analysis
  • Oral Contraceptives
    • Market Analysis
  • Osteoporosis and Hormone Replacement Therapy
    • Market Analysis
  • Overactive Bladder
    • Market Analysis
  • Sexual Dysfunction
    • Viagra
    • Market Analysis
  • Sleep Agents
    • Ambien
    • Lunesta
    • Provigil
    • Market Analysis
  • Smoking Cessation
    • Nicotrol Inhalation and Nasal Spray
    • Zyban
    • Market Analysis
  • Viral Infections
    • Tamiflu
    • Valtrex
    • Market Analysis
  • Others
    • ReVia
    • Market Analysis

CHAPTER THREE: ISSUES AND TRENDS AFFECTING THE RX-TO-OTC SWITCH INDUSTRY

  • Proposed Legislation
  • Consumers and Rx-to-OTC Switches
  • Direct-to-Consumer (DTC) Advertising
  • Patient Safety
  • FDA Again Considering Third Class of Medicines
  • Insurance Reimbursement Issues
  • OTC Switch Criteria and FDA Involvement
  • Competition Strategies

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1: Major Markets for Rx to OTC 2008 and 2010
  • Figure 2: Number of New Rx-to-OTC Switches per Year 1976-2007

CHAPTER TWO: RX-TO-OTC PRODUCT AND MARKET ANALYSIS

  • Figure 3: Revenue, Major Rx to OTC Categories, 2008
  • Table 1: Potential Rx-to-OTC Switches, 2008-2013
  • Table 2: Rx-to-OTC Market Analysis: Allergy and Cold Treatments
  • Table 3: Rx-to-OTC Market Analysis: Antilipidemic Agents
  • Table 4: Rx-to-OTC Market Analysis: Fungal Infection Treatments
  • Table 5: Rx-to-OTC Market Analysis: Gastrointestinal Treatments
  • Table 6: Rx-to-OTC Market Analysis: Hair Loss Treatments
  • Table 7: Rx-to-OTC Market Analysis: Migraine Therapies
  • Table 8: Rx-to-OTC Market Analysis: NSAIDs
  • Table 9: Rx-to-OTC Market Analysis: Oral Contraceptives
  • Table 10: Rx-to-OTC Market Analysis: Sleep Agents
  • Table 11: Rx-to-OTC Market Analysis: Smoking Cessation

CHAPTER THREE: ISSUES AND TRENDS AFFECTING THE RX-TO-OTC SWITCH INDUSTRY

  • Table 12 Leading Rx-to-OTC Switches 1994-2007
  • Figure 1: Number of New Rx-to-OTC Switches per Year 1976-2007
  • Table 13: Health Insurance Trends in the United States 2003-2006

 

    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
    August 2, 2022
    100 Companies in Contract Pharmaceutical Research – White Paper
    March 27, 2018
    Biopharmaceutical Contract Manufacturing (BCMO) Market – by Type of Service, by Organization and by Region
    November 29, 2017
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, Forecasts to 2018, 6th Edition
    April 30, 2014

Related products

  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    Growth Factors: Indications, Products, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    World Market for Anti-infectives Volume III: The World Market for Antiviral Medications, The

    $1,875.00 – $3,750.00
  • Placeholder image

    Neurologic Cancers: Selections from “The World Market for Neurotherapeutic Drugs”

    $1,121.00 – $1,717.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches,...Wireless in Healthcare (Hospital, Physician Office, Pharmaceutical and other...
Scroll to top